Viewing Study NCT03373253



Ignite Creation Date: 2024-05-06 @ 10:53 AM
Last Modification Date: 2024-10-26 @ 12:36 PM
Study NCT ID: NCT03373253
Status: COMPLETED
Last Update Posted: 2022-02-03
First Post: 2017-12-08

Brief Title: Treatment-Resistant Depression Cohort in Europe
Sponsor: Janssen-Cilag Ltd
Organization: Janssen-Cilag Ltd

Study Overview

Official Title: Treatment-Resistant Depression Cohort in Europe
Status: COMPLETED
Status Verified Date: 2022-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess the participants socio-demographics and disease-related characteristics long-term naturalistic treatment patterns and the clinical social and economic outcomes of routine clinical practice in the treatment of participants with treatment-resistant depression TRD in a variety of European countries
Detailed Description: This TRD cohort study will collect critically important data from routine clinical practice in Europe which will further substantiate the understanding of TRD in European clinical practice with the aim of improving guidance and informing the development of better treatment strategies for this medically important condition All data recorded in the case report form CRF should be documented in participants medical records that will be the primary data source of each participant Participants who meet the diagnostic criteria for Major Depressive Disorder MDD and the diagnostic criteria for TRD and are initiating or planned to initiate a new antidepressive treatment regimen will participate in the study The end of the entire study will be 6 months after enrollment of the last participant in the study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
54135419DEP4001 OTHER Janssen-Cilag Ltd None